(FVCH) Franklin MSCI China Paris - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE000EBPC0Z7

China Stocks, Equity, Shares, Investments

Description: FVCH Franklin MSCI China Paris

URL: http://www.franklintempleton.lu Index: Morningstar China TME NR USD

Additional Sources for FVCH ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

FVCH ETF Overview

Market Cap in USD 8m
Category China Equity
IPO / Inception 2022-06-14

FVCH ETF Ratings

Growth Rating -3.33
Fundamental -
Dividend Rating 0.0
Rel. Strength -2.26
Analysts -
Fair Price Momentum 19.31 EUR
Fair Price DCF -

FVCH Dividends

Currently no dividends paid

FVCH Growth Ratios

Growth Correlation 3m 31.5%
Growth Correlation 12m 65.5%
Growth Correlation 5y -29.3%
CAGR 5y -4.81%
CAGR/Max DD 5y -0.11
Sharpe Ratio 12m -0.29
Alpha 15.04
Beta 0.464
Volatility 21.06%
Current Volume 0k
Average Volume 20d 0k
Stop Loss 19.6 (-3.4%)
What is the price of FVCH shares?
As of July 09, 2025, the stock is trading at EUR 20.29 with a total of 5 shares traded.
Over the past week, the price has changed by +0.67%, over one month by -2.99%, over three months by +6.57% and over the past year by +27.43%.
Is Franklin MSCI China Paris a good stock to buy?
Neither. Based on ValueRay´s Analyses, Franklin MSCI China Paris is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -3.33 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FVCH is around 19.31 EUR . This means that FVCH is currently overvalued and has a potential downside of -4.83%.
Is FVCH a buy, sell or hold?
Franklin MSCI China Paris has no consensus analysts rating.
What are the forecasts for FVCH share price target?
According to our own proprietary Forecast Model, FVCH Franklin MSCI China Paris will be worth about 21.6 in July 2026. The stock is currently trading at 20.29. This means that the stock has a potential upside of +6.51%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 21.6 6.5%